ICICI Prudential Life names new CEO: key 2026 dates

What the board decided and why it matters

ICICI Prudential Life Insurance has announced a top leadership transition that will take effect in October 2026. The insurer’s board approved the appointment of Sidharatha Mishra as Managing Director and Chief Executive Officer, subject to regulatory and other requisite approvals. The change follows the resignation of the incumbent MD and CEO, Anup Bagchi. The company disclosed the development through a stock exchange filing dated October 2, 2026.

The appointment is structured as a staged handover. Mishra is set to first take charge as Chief Operating Officer (COO) from October 6, 2026. He is then expected to assume the MD and CEO role from October 14, 2026, or upon receipt of approval from the Insurance Regulatory and Development Authority of India (IRDAI), whichever is later. The stated term for the MD and CEO role is five consecutive years, subject to approvals.

Sidharatha Mishra’s appointment: role, timing, and term

As per the disclosures, ICICI Life’s board approved Mishra’s appointment as an Additional Director, and as Managing Director and Chief Executive Officer. The effective date is October 14, 2026, or the date of IRDAI approval, whichever is later. The insurer has indicated the MD and CEO appointment is for a period of five consecutive years, subject to requisite approvals.

In parallel, the board also approved his appointment as Chief Operating Officer with effect from October 6, 2026. This sequencing positions Mishra to move into the CEO role after a short operational transition period. The company has also stated that, as MD and CEO, Mishra will be responsible for steering business operations, the growth strategy, and customer-focused initiatives.

Transition plan: COO first, then MD and CEO

The transition has been designed to take place in stages across October. Mishra will take charge as COO on October 6, before the planned move to MD and CEO. The MD and CEO start date is linked to regulatory approval, which means the final effective date could be later than October 14 if IRDAI approval is received after that date.

This type of sequencing is often used to maintain continuity in senior management responsibilities. The company has explicitly framed the move as part of a leadership changeover, with Mishra stepping into the COO role ahead of the final CEO appointment. The board’s approvals cover his elevation through both roles, along with his appointment as an Additional Director.

Anup Bagchi’s resignation and his next role

The board of ICICI Life took on record the resignation tendered by Anup Bagchi as Managing Director and CEO. His resignation is effective from the close of business hours on October 13, 2026. Bagchi is stepping down to take over as MD and CEO of HDFC Bank from October 27.

The information disclosed also notes that the Reserve Bank of India (RBI) approved Bagchi’s appointment and remuneration on October 1, with his term scheduled to begin on October 27. The disclosures further state that Bagchi has been MD and CEO of ICICI Prudential Life since June 2023.

Regulatory approvals: IRDAI and other requisite clearances

ICICI Prudential Life has consistently linked Mishra’s MD and CEO start date to IRDAI approval. Across the exchange filings and the press disclosures, the effective date is described as October 14, 2026, or the date of receipt of IRDAI approval, whichever is later. In addition, the appointment is described as being subject to regulatory and other requisite approvals.

This framing is important because it sets the conditions under which the appointment becomes operational. While the board has approved the change, the final start is not unconditional. The company has not provided a specific timeline for when IRDAI approval is expected, only the condition that the MD and CEO term begins once approval is received.

Board process and disclosures to exchanges

The insurer said the board decision was taken at its meeting held on October 2, 2026. It also noted that the appointment followed the recommendation of the Board Nomination and Remuneration Committee. The leadership change was communicated through regulatory disclosures, including an exchange filing.

The company’s board also recorded Bagchi’s resignation at the same meeting, noting the effective date as the close of business on October 13, 2026. The disclosures include the directors’ identification numbers as part of the regulatory filing format, listing Bagchi’s DIN as 00105962 and Mishra’s DIN as 06524169.

Key facts at a glance

Market impact: what changes and what does not

The disclosed changes are focused on senior management and board-level roles, rather than any alteration to the insurer’s products or capital structure. The transition introduces a defined handover period, with Mishra taking on COO responsibilities before moving into the MD and CEO role. For investors and stakeholders, the key operational detail is the conditionality on IRDAI approval, which can affect the exact date on which the CEO appointment becomes effective.

The resignation and appointment were communicated through stock exchange filings, signalling that the company is treating the development as material information for the market. The company has not released any financial projections or operating metrics alongside the leadership change, and none are required to understand the appointment timeline.

Why the event matters: governance and continuity

CEO transitions in regulated financial businesses typically require a clear sequence of approvals and defined effective dates. Here, ICICI Prudential Life has set out specific dates for the interim role (COO from October 6) and the planned CEO start date (October 14), while acknowledging the final condition of IRDAI approval.

The board’s decision also reflects a structured governance process. The appointment followed a recommendation from the Board Nomination and Remuneration Committee, and was approved at a board meeting with details subsequently disclosed through exchange filings. The inclusion of an Additional Director appointment alongside the MD and CEO role shows that the company is aligning board and executive responsibilities as part of the change.

What to watch next

The next formal milestone is the receipt of IRDAI approval, which will determine whether the MD and CEO appointment becomes effective on October 14 or later. Separately, Bagchi’s resignation takes effect at the close of business on October 13, and his move to HDFC Bank is scheduled from October 27.

The company has already mapped out the internal transition by placing Mishra in the COO role from October 6. Any further updates are likely to come through additional exchange filings once regulatory approvals and effective dates are confirmed.

Conclusion

ICICI Prudential Life has approved Sidharatha Mishra’s appointment as MD and CEO for a five-year term, with a staged transition that begins with his COO role from October 6, 2026. Anup Bagchi will step down from the insurer effective October 13, ahead of taking charge at HDFC Bank from October 27. The key outstanding step for the insurer is IRDAI approval, which will determine the final effective date of Mishra’s MD and CEO appointment.